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et al., 2009). In particular, actinomycetes from 
less-explored habitats show exceptional promise to 
produce novel antimicrobial compounds (Genilloud et 
al., 2011).  This was already anticipated by Groth et 
al. (1999) in a study on the Spanish caves of Altamira 
and Tito Bustillo. For instance, a new antimicrobial-
producing actinomycete strain, Streptomyces 
tendae HKI 0179, was isolated from the ancient 
cave Grotta dei Cervi in Italy by Groth et al. (2001). 
Streptomyces tendae HKI 0179 produced novel forms 
of antimicrobials called cervimycins (Herold et al., 
2005) which showed high levels of antimicrobial 
activities against the pathogens Bacillus subtilis, 
multi-drug resistant Staphylococcus aureus (MRSA), 
and vancomycin-resistant Enterococcus faecalis (VRE) 
1528. These antimicrobials were as effective as those 
such as vancomycin, tetracycline, and ciprofloxacin 
that are currently used to treat infections caused 
by these organisms. A recent study by Rajput et 
al. also discovered several Streptomyces strains 
(Streptomyces prasinosporus KCA strains 3, 8, and 
22, Streptomyces aurantiacus KCA6, Streptomyces 
INTRODUCTION
Antibiotic resistance continues to pose a significant 
threat to the clinical and pharmaceutical world. Many 
common hospital pathogens are becoming multi-drug 
resistant and are unable to be treated with many -if 
any- of the commercially available antibiotics (Davies 
& Davies, 2010). Multi-drug resistant microorganisms 
are a significant problem as they are a leading cause 
of human death worldwide (Selvameenal et al., 2009) 
and antibiotics are still currently the only effective way 
to treat infectious microbial diseases. Thus, the need 
for novel antimicrobial compounds is greater now than 
ever before. Fortunately, filamentous, Gram-positive 
bacteria known as the actinomycetes-particularly 
the Streptomyces species- produce antimicrobials 
in nature and have been the largest source of new 
antibiotic drug candidates and leading molecules 
to date (Genilloud et al., 2011). Out of the 22,500 
secondary metabolites with antimicrobial activities 
that have been found in studies, 10,100 (or 45%) 
have been produced by actinomycetes (Selvameenal 
The goal of this study was to determine whether actinomycetes isolated from a volcanic 
cave in western Canada could produce novel antimicrobial compounds against six multidrug-
resistant pathogens when exposed to UV light.  One hundred and seventy-six actinomycete 
strains isolated from Helmcken Falls Cave, Wells Gray Provincial Park, BC, were screened 
against six pathogens using the “plug assay” in UV light and no light conditions. Of the 176 
strains tested, 100 or 57% of the cave actinomycete strains had antimicrobial activities 
against the pathogens in 124 different instances: 35 instances when exposed to UV and 
no light, 30 when exposed to UV light, and 59 instances when exposed to no light. The 
metabolites of six actinomycete strains also lost their antimicrobial activities when exposed 
to UV light.  While the metabolites produced by these strains have yet to be determined, 
exposure to lighted environments may either deactivate or enhance the antimicrobial activities 
of cave actinomycete strains. This study represents a confirmation that cave actinomycetes 
are potential sources of novel antimicrobial compounds and also is the first report of the 
enhancement of antimicrobial activities of some cave bacteria by exposure to UV light. Further 
investigation of the role of UV light with respect to activation/deactivation of antimicrobial 
activities of cave actinomycetes is required.
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Growth of the pathogens
The six pathogen strains used in this project include: 
Mycobacterium smegmatis strain JVC1213 (MC2155), 
Extended Spectrum β-Lactamase (ESBL)-producing 
Escherichia coli strain 1841 JVC1195, Micrococcus 
luteus, Multi-Drug Resistant Staphylococcus aureus, 
Acinetobacter baumannii strain 14394, and Candida 
albicans (Table 1).  The pathogens were provided 
by Dr. Julian Davies from the University of British 
Columbia (UBC), in Vancouver, BC and Dr. Gwen 
Stephens from the Department of Pathology at the 
Royal Inland Hospital (RIH), in Kamloops, BC. 
To culture the pathogens, a loopful or bead (if taken 
from the -80oC freezer) of each pathogen was placed 
into 40 mL of liquid broth medium that is known to 
encourage the growth of each strain (Table 1).  The 
flask was then incubated at either 35°C or 25°C (for 
Candida albicans) on an orbital shaker at 200 rpm. 
Optical density readings of each pathogen at 600 nm 
wavelength were recorded and matched with the 0.5 
McFarland standard for logarithmic growth. 0.5% of 
each pathogen was then transferred to the molten 
agar prepared for the bioassay as described below.  
Conventional Agar Plug Assay
To screen for antimicrobial activity of the 
metabolites of the cave actinomycetes against the six 
multi-drug resistant pathogens, a series of seeded 
bioassay plates were prepared using the conventional 
agar plug assay (Murakami et al., 1986) also known 
as the agar plug method. Each of the six pathogens 
was grown separately in liquid medium as described 
above. Then, 0.5% (v/v) (1.25 mL) of each pathogen at 
log phase was added to two 250 mL flasks of molten 
nutrient agar (potato-dextrose-agar in the case of 
Candida albicans) which were kept warm in a 55°C 
water bath. The agar was then poured into two 25 
by 25 mm square bioassay plates. After solidification, 
agar plugs of the cave actinomycete strains (these cave 
actinomycetes had already been cultured for 7 to 10 
days prior to this step to ensure secondary metabolite 
production) were transferred onto each of the two 
identical bioassay plates in the same pattern using 
the open ends of sterile 20-200 µL pipette tips (Fig. 1). 
A disk impregnated with sterile water was also added 
to each of the plates as a negative control, while a disk 
roseus KCA13, Streptomyces longiosporoflavus 
KCA18, and Streptomyces luridus KCA23) isolated 
from the Kotsumar Cave in India that produced 
significant antimicrobial activities against the three 
drug-resistant human pathogens Pseudomonas 
aeruginosa, Escherichia coli, and Staphylococcus 
aureus (Rajput et al., 2012). Overall, these studies 
show that natural antimicrobial compounds produced 
by cave actinomycetes are strong contenders for the 
new antimicrobials that are needed to ease the multi-
drug resistance problem.
Previous studies have shown an increasing number 
of fungal and plant natural products that have light-
mediated activities against fungi, insects, bacteria, 
viruses, and cells (Towers et al., 1997). A study carried 
out by Hudson and colleagues in 2000, for example, 
tested the antiviral activities of seven species of African 
medicinal plant extracts that were exposed to long-
wave UV light (UVA, which has a wavelength of 315-
400 nm) and fluorescent light (visible light, which has 
a wavelength of 185-254 nm) against the type 1 herpes 
simplex virus (Hudson et al., 2000). The plant extracts 
showed the most antiviral activities against the virus 
when the extracts were exposed to light, particularly 
UVA light. Similarly, Cheeptham and Towers studied 
the light-mediated activities of a wide variety of Thai 
medicinal plant tea extracts in 2002 (Cheeptham & 
Towers, 2002). They too demonstrated the remarkable 
ability of plant extracts to produce antimicrobial and 
antifungal compounds against an array of bacterial 
and fungal pathogens when subjected to UV light 
(from 5 W/m2, 320-400 nm Sylvanian F20T12-BLB 
lamps). Thus, investigation as to whether UV light 
can stimulate the metabolites of cave actinomycetes 
to produce antimicrobial activities for a potentially 
wider and more specific therapeutic use would be of 
great benefit. 
MATERIALS AND METHODS
Organisms and growth conditions
Growth of the cave actinomycete strains
One hundred and seventy-six cave actinomycete 
strains of over 400 strains previously isolated from 
Wells Gray Provincial Park in Clearwater, BC, Canada 
were primarily subcultured onto 25-30 mL Hickey 
Tresner (HT) agar plates (10 g/L dextrin, 1 g/L yeast 
extract, 1 g/L beef extract, 2 g/L N-Z Amine Type 
A, 15 g/L agar, pH 7.3) using the confluent-streak 
technique. The plates were incubated at 25°C for 7 
to 10 days.  For the strains that did not grow well, 
a “plug” of each strain was transferred -using the 
open end of a 20-200 µL pipette tip (sterile)- from its 
original stock plate to a fermentation tube (13x100 
mm size) with six mL of HT broth. The tubes were 
then placed in a 25°C shaker for approximately 7 
to 10 days to obtain uniform growth. Each of the 
isolates was confluent-streaked onto HT agar plates 
using sterile polyester tipped applicators (swabs) and 
was then incubated at 25oC for 7 to 10 days.  These 
plates were then used as the origin of the plugs for 
the bioassay.
Drug- Resistant 
Pathogen
Medium 
Used
Gram 
Reaction
OD600 
Values 
at Log 
Phase
Approximate 
Time Required 
to Reach Log 
Phase (hrs)
Mycobacterium 
smegmatis strain 
JVC1213 (MC2155)
N.E. + 0.7 82
ESBL-producing 
Escherichia coli strain 
1841 JVC1195
L.B. - 0.6 6
Micrococcus luteus N.B. + 0.6 12
MDR-S. aureus L.B. + 0.5 5
Acinetobacter 
baumannii
strain 14394
N.B. - 0.6 12
Candida albicans Y.M. mold (yeast) 0.7 24
The medium that each pathogen was grown in, the pathogen’s Gram 
reaction and optical density value (OD600) at log phase, and the 
approximate amount of time required to reach the pathogen’s log 
phase (hrs) is also given.
Table 1. Six antimicrobial-resistant pathogens used in this study.
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metabolites, producing not much more than a six mm 
zone of inhibition against ESBL-producing Escherichia 
coli in no light conditions.  Also, it seems that 
Mycobacterium smegmatis and Candida albicans were 
the most susceptible pathogens to the antimicrobial 
activities of the cave actinomycetes’ metabolites in 
this study. The metabolites of 49 cave actinomycete 
strains produced antimicrobial activities against 
Mycobacterium smegmatis, while the metabolites of 
46 strains produced antimicrobial activities against 
Candida albicans (Table 4). The metabolites of six 
cave actinomycete strains lost their antimicrobial 
activities when they were exposed to one hour of UV 
light, as well (Table 5).  The identification of the six 
cave actinomycetes by 16S rRNA sequencing is shown 
in Table 6.
soaked with 3 or 5 mg of 8-methoxypsoralen (8-MOP; 
a common substance that is light-reactive and can 
be used to show antimicrobial activity) in one mL of 
methanol was added to each plate as a UV indicator 
(or light-activated activity positive control).
Subsequently, one of the assay plates was subjected 
to one hour of UV light (254 nm) in the Labconco Flow 
Hood with its lid open, while the other plate received 
no UV light treatment and sat in the dark lab for an 
hour. Afterwards, the lid was placed back on the UV 
light plate and both the UV and no light plate were 
incubated overnight at 35°C (25° for C. albicans) in 
the dark lab. Any inhibitory zones and their diameters 
were measured and recorded after the incubation 
period. The positive controls for antimicrobial activity 
used in this study varied depending on the pathogens 
used in the assay plates (Table 2).
RESULTS
Of the 176 strains tested, the metabolites of 
57% or 100 of the cave actinomycete strains had 
antimicrobial activities against the six pathogens 
tested in 124 different instances. In 35 instances the 
metabolites had antimicrobial activities in both UV 
and no light, in 30 instances they had antimicrobial 
activities in UV light, and in the remaining 59 
instances they had antimicrobial activities in no light 
(Fig. 2, Table 3).  
Notably, no single cave actinomycete isolate produced 
metabolites with antimicrobial activities against 
all six of the pathogens. Strain E9’s metabolites, 
however, produced antimicrobial activities against all 
of the pathogens except for Candida albicans (Table 
4). The metabolites of cave actinomycete strain 100 
showed the greatest antimicrobial activities of all of 
the metabolites, producing a zone of inhibition 27 
mm in diameter against Candida albicans in UV light 
conditions (Table 4). Conversely, E25’s metabolites 
showed the least antimicrobial activities of all of the 
Pathogen Antibiotic Disk Used as a Positive Control
Mycobacterium smegmatis JVC 1213 
(MC2155)
SXT (sulfamethoxazole- 23.75 µg, and 
trimethoprim- 1.25 µg)
ESBL-producing Escherichia coli  
strain 1841 JVC1195 CFP (cefoperazone- 75 µg)
Micrococcus luteus TET (tetracycline- 30 µg)
MDR-S.aureus TET (tetracycline- 30 µg)
Acinetobacter baumannii  strain 14394 CAZ (ceftazidime -30 µg)
Candida  albicans N/A – antifungal (nystatin- 20 µg)
Table 2. Positive controls against the six antimicrobial-resistant 
pathogens used in this study.
Fig. 1. An example of a seeded plate prepared using the “plug assay” 
to assess the antimicrobial activities of the cave actinomycete strains’ 
metabolites against the antimicrobial-resistant pathogen Micrococcus 
luteus when the metabolites were exposed to UV light. The diameters 
of the dark, inhibitory zones that encircle the actinomycete plugs were 
measured to assess the antimicrobial activities of the metabolites.
 Conditions
Pathogen UV light Non-UV Both Total
M. luteus 2 7 4 13
MDR-S. aureus 1 2 1 4
M. smegmatis 11 28 10 49
ESBL- producing- E. coli 0 3 0 3
A. baumannii 0 6 3 9
C. albicans 16 13 17 46
Total 30 59 35 124
The pathogens that were most susceptible to the metabolites of the 
cave actinomycetes are shaded. The total number of metabolites 
that had antimicrobial activities against the pathogens in each of the 
different conditions is also given.
Table 3. The number of cave actinomycete strains’ metabolites that 
had antimicrobial activities against the six drug-resistant pathogens in 
different conditions.
Fig. 2. The number of cave actinomycete strains’ metabolites that had 
antimicrobial activities against the six drug-resistant pathogens in UV 
light, no light, and both UV light and no light conditions.
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used).  Regardless, the metabolites produced by 
the cave actinomycete strains in this preliminary 
study appear to be fairly effective antimicrobial and 
antifungal agents against Mycobacterium smegmatis 
(which is a model organism for the tuberculosis drug 
search) and Candida albicans in particular, and may 
have valuable clinical applications in the future. 
The percentage of cave actinomycete strains that 
produced antimicrobials against the pathogens in 
our project is comparable to the percentage of cave 
Streptomyces strains that produced antimicrobials 
against the pathogens in another recent study (Yücel & 
Yamaç, 2010).  These authors tested 290 Streptomyces 
strains isolated from several caves in Turkey for their 
antimicrobial activities against MRSA, VRE, and 
Acinetobacter baumannii. They found that 62% or 180 
out of 290 strains produced antimicrobial activities 
against these pathogens in the primary screening 
process, which is similar to the 57% or 100 out of 
176 actinomycete strains that produced antimicrobial 
activities against the pathogens in our project. 
Conversely, the percentage of cave actinomycete 
strains that produced antimicrobials against the 
pathogens in our project is high compared to a 
study conducted by Montano & Henderson in 2012 
to determine the effects of nutrient level and human 
visitation on the antimicrobial activity of cave bacteria 
from three carbonate caves in Carlsbad Caverns 
National Park, New Mexico, USA. In this study, 21.1% 
of the isolates taken from the Backcountry Cave, 
19.8% of the isolates taken from the Spider Cave, and 
8.62% of the isolates derived from the Fort Stanton 
Cave showed antimicrobial activity against at least one 
of the five target bacterial pathogens tested against in 
the experiment (Staphylococcus aureus (ATCC 6538), 
Klebsiella pneumoniae (ATCC 13883), Proteus vulgaris 
(ATCC 13315), Shigella flexneri (ATCC 9199), and 
Streptococcus pneumoniae (ATCC 6303), compared to 
the 57% of cave actinomycete strains that produced 
antimicrobial activity against the pathogens in our 
project. On the other hand, a second study conducted 
by Montano and Henderson in 2012 to examine the 
effects of a lack of nutrients and cave depth on the 
antimicrobial activity of cave bacteria from three 
carbonate caves in Carlsbad Caverns National Park, 
New Mexico, USA,  showed more comparable results 
to our study. In this study, 66% of the isolates in the 
Left Hand Tunnel passage in Carlsbad Caverns, 24% 
of the isolates in Spider Cave, 24% of the isolates 
in Backcountry Cave, and 40% of the isolates in 
 Pathogen
Actinomycete 
strain
M. 
luteus
MDR- 
S.aureus
M.
smegmatis
ESBL
E. coli
A. 
baumannii
C. 
albicans
E9 16 13 20 7 13 0
E9 12 9.5 0 0 0 0
100 0 0 9 0 0 27
E25 12 13.5 0 6 0 0
E25 11 0 0 0 0 0
Table 4. The antimicrobial activities of the metabolites of cave 
actinomycete strains E9, PM100 and E25 against the six 
antimicrobial-resistant pathogens used in this project. The diameters 
of the zones of inhibition produced by the metabolites are given in 
millimetres (mm). The shaded boxes highlight the metabolites that 
had antimicrobial activities in UV light conditions.
Pathogen
Actinomycete 
Strain
M. 
luteus
MDR- 
S.aureus 
M. 
smegmatis
ESBL- 
E.coli
A. 
baumannii
 C. 
albicans
PM 106 
(DR031) 0 0 19 0 19 10
PM 106 
(DR031) - - 17 - 17 -
NC-18 15 7 0 0 12 0
NC-18 12 - - - - 0
NC-39 8 0 13 0 0 10
NC-39 - - 19 - - 26.5
E9 16 13 20 7 13 0
E9 12 9.5 - - - 0
E25 12 13.5 0 6 0 0
E25 11 - - - - 0
unknown 9 11 0 8 0 0 0
unknown 9 11 - - - - 0
Table 5. The metabolites of six cave actinomycete strains that lost their 
antimicrobial activities under UV light exposure. The diameters of the 
zones of inhibition produced by the metabolites on the seeded plates are 
given in millimetres (mm). Shaded bars represent non-UV light conditions 
while the white bars represent UV light conditions. The outlined boxes 
highlight the instances where the metabolites of the cave actinomycete 
strains lost their antimicrobial activities in UV light conditions.
Table 6. Identification of some cave actinomycetes by 16S rRNA 
sequencing (Cheeptham et al., 2013).
Actinomycete 
strain
Species (Identified by 16S rRNA 
sequencing) % similarity Accession # 
PM 106 Streptomyces microflavus 99 JQ422124
NC-18 Streptomyces coelescens 99 JQ422176
NC-39 Streptomyces phaechromogenes NRRL1248 99 JQ422177
E9 Streptomyces durmitorensis 99 JQ422178
E25 Streptomyces sp. 82293 99 JQ422179
SK119 Erwinia sp. 99 JQ422180
Unknown 9 Not sequenced N/A N/A
DISCUSSION
Based on the results observed from the agar plug 
assay tested in our study, cave actinomycetes have the 
potential to produce antimicrobial compounds that 
are needed to help combat the antibiotic resistance 
phenomenon. In particular, the antimicrobial 
compounds produced by strain E9 in our study 
were effective against many different pathogens and 
may have the potential to be developed into broad-
spectrum antibiotics in the future.  However, the 
chemical composition and modes of action of the 
antimicrobials produced in our study have yet to be 
determined by isolating the metabolites with high-
performance liquid chromatography and examining 
their structures with mass spectrometry and nuclear 
magnetic resonance spectroscopy, as suggested by a 
previous study (Herold et al., 2005). The media used 
for antimicrobial production in the current study also 
need to be optimized in order to obtain the highest 
yield of metabolites as possible (only HT agar was 
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remained the same for Enterobacter faecalis and 
Mycobacterium phlei when the extracts were exposed 
to UV light and no light conditions and no extract 
had light-mediated antimicrobial activities against 
Escherichia coli.  Conversely, to our knowledge, no 
previous study has looked at the effects of UV light 
on the deactivation/activation of the antimicrobial 
activities of bacterial metabolites from cave 
actinomycetes.  Photoactivation of metabolites by 
UV light may act as a novel source of drug discovery 
and more specifically, narrow spectrum antibiotics.
Future work should also examine the effects of 
UV light exposure on the cave actinomycete strains 
and pathogens that were used in this project. These 
microorganisms were also exposed to UV light 
during our project which may have had significant 
implications on the results obtained from our study. 
Short wave UV light exposure is known to cause 
extensive damage and mutations to arise in bacterial 
DNA (Snider et al., 2009). It triggers the formation 
of pyrimidine dimers that alter the structures of 
the nucleic acids and prevents DNA polymerase 
from replicating bacterial DNA (Farrell et al., 
2009).  However, some bacteria possess DNA repair 
mechanisms such as excision repair, post replication 
repair (Snider et al., 2009), SOS-repair (Chapple et 
al., 1992), and photoreactivation (Sayed 2011), which 
allow them to repair DNA damage caused by UV 
radiation exposure.
A study carried out by Farrell and colleagues in 2009 
looked at the effects of pulsed light rich in UV-C waves 
(200-280 nm) on the inactivation of clinical pathogens 
such as Staphylococcus aureus, Enterococcus faecium, 
Acinetobacter baumannii, Escherichia coli and 
Pseudomonas aeruginosa (Farrell et al., 2009).  One 
pulse per second of pulsed light was administered 
and the amount of light pulses given varied from 
0 to 60. The distance of the light source from the 
pathogens ranged from 8-20 cm.  Overall, the levels of 
each of the pathogens were reduced by approximately 
7 log10 CFU cm
-2 with exposure to the pulsed light. 
Greater inactivation occurred as the intensity of the 
light source and the number of pulses increased, and 
as the distance of the pathogen plates from the light 
source decreased. Thus, it is possible that the levels of 
the pathogens used in our project may have decreased 
with UV light exposure as described by these studies. 
Future aspects for our next study should explore 
this possibility, along with the effects of different UV 
exposure times on the pathogens used in the current 
study, as all plates were previously exposed to one 
hour of UV light.
Similarly, the response of cave bacteria to UV light 
was previously measured in a study conducted by 
Northup et al. (2004).  In this study, bacterial cultures 
from Four Windows Cave, a lava tube in New Mexico, 
USA, were tested for their sensitivity to a 100 and 50 
second dosage of UV light.  All of the strains tested 
showed varying sensitivity to the 100 second dose of 
UV light, while all but four strains were sensitive to 
the 50 second dose of UV light.  The bacterial strains 
taken from inside the cave were also more sensitive 
to UV light than the bacterial strains taken from the 
Lechuguilla Cave had antimicrobial activity against at 
least one of the five pathogens listed in Montano & 
Henderson’s first study above. 
Similarly, numerous recent studies have also 
isolated novel Streptomyces strains from cave and 
desert soils that produced antimicrobial compounds 
against a variety of drug-resistant pathogens.  For 
instance, earlier this year, Rajput and colleagues 
discovered seven novel streptomycete strains isolated 
from the Kotsumar Cave in India that had varying 
antimicrobial activities against Staphylococcus 
aureus MTCC 96, Escherichia coli MTCC 1667, and 
Pseudomonas aeruginosa JNMC (Rajput et al., 2012). 
Likewise, in 2005, Herold and colleagues discovered 
that the novel Streptomyces tendae strain HKI 0179 
isolated from an ancient cave in Italy Grotta dei Cervi 
produced antimicrobial activities against Bacillus 
subtilis ATCC 6633, Staphylococcus aureus SG511, 
Staphylococcus aureus 134/93, vancomycin-resistant 
Enterococcus faecalis 1528 and efflux-resistant 
Staphylococcus aureus EfS4 (Herold et al., 2005). As 
well, in 2009, Selvameenal and colleagues showed 
that the novel Streptomyces hygroscopicus subsp. 
ossamyceticus strain D10 isolated from desert soil 
in Rajasthan, northwest India produced a range 
of antimicrobial activities against Staphylococcus 
aureus, vancomycin-resistant Staphylococcus aureus, 
extended spectrum β-lactamase (ESBL)-producing 
Escherichia coli and Klebsiella sp. (Selvameenal et al., 
2009).  Based on the results of these studies and the 
results of this project, the future of isolating novel 
antimicrobial-producing bacterial strains from less-
explored habitats such as caves is promisingly bright.
The effects of UV light on the antimicrobial 
activities of cave actinomycete metabolites in our 
study are preliminary and must continue to be 
investigated in the future. Previous studies have 
shown that some plant metabolites are able to be 
photoactivated against a number of pathogens 
with exposure to UV light (Towers et al., 1999; 
Cheeptham & Towers, 2002; Hudson et al., 2002). 
In addition, a study carried out by Matias et al. 
in 2010 identified several Brazilian medical plant 
extracts whose antimicrobial activities against 
Staphylococcus aureus were enhanced when the 
extracts were exposed to two hours of UV light (5 
W/m2, 320-400 nm from four Sylvania F20T12-BLB 
lamps, maximum emission at 350 nm- Matias et al., 
2010). Similarly, in 2002, Rajakaruna and colleagues 
tested the antimicrobial activities of the extracts 
of 32 species of Sri Lankan plants against seven 
pathogens (MRSA, Bacillus subtilis, Enterobacter 
faecalis, Escherichia coli, Pseudomonas aeruginosa 
H187 (wild type), Mycobacterium phlei, and Candida 
albicans) when the extracts were subjected to 
45 minutes of long wave UV light (Sylvania, 
F20T12/BLB, 20W, four bulbs – Rajakaruna et 
al., 2002).  Ten extracts showed light-activated 
antimicrobial activities against six of the pathogens. 
Antimicrobial activity was enhanced with UV light 
exposure against Staphylococcus aureus, Bacillus 
subtilis, and Pseudomonas aeruginosa. However, 
the antimicrobial activity levels of the extracts 
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